24 March 2017 – This new WHO policy guidance provides countries with a set of tools and strategies for achieving and maintaining malaria elimination. The guidance recognizes that malaria transmission represents a continuum; programme actions are highlighted across the spectrum of transmission intensity, from high to very low. The framework includes a streamlined process for WHO certification of malaria elimination and clarifies the threshold for reestablishment of transmission.
15 March 2017 – Members of the Malaria Policy Advisory Committee (MPAC) will convene in Geneva, Switzerland, on 22–24 March.The agenda includes, among other topics, updates on the RTS,S malaria vaccine, malaria-eliminating countries and HRP2/HRP3 deletions. The Committee will also review an Operational manual on surveillance, monitoring and evaluation and an Operational manual on mass drug administration.
28 February 2017 – Members of the WHO Strategic advisory group (SAG) on malaria eradication recently convened in Geneva to review and define a set of work streams for the next 2-year period. The proposed scope of work is cross-cutting and spans a breadth of domains: biological, technical, financial, socio-economic, political and environmental.
3 February 2017 – The WHO Executive Board recently reviewed the proposed Global vector control response 2017–2030. In view of Member States’ strong support for the proposed plan, the Board requested that the WHO Secretariat, in collaboration with interested Member States, prepare a resolution for consideration by all 192 Member States at the Seventieth World Health Assembly in May 2017.
This end-of-year video spotlights key developments in the global response to malaria in 2016. It highlights the launch of a new malaria strategy in India, elimination in the European Region, and elimination certification in Sri Lanka. Other topics include the pilot deployment of the world’s first malaria vaccine and the convening of a new WHO advisory group on malaria eradication.
Areas of work
- Diagnostic testing
- Drug resistance and response
- Entomology and vector control
- Malaria elimination
- High-risk groups
- Malaria vaccine development
- Preventive therapies
Fact sheets and Q&As
- WHO fact sheet on malaria
- Q&A on malaria vaccine RTS,S
- Q&A on insecticide resistance
- Q&A on artemisinin resistance
Global Fund – funding proposal development
- Test procedures for insecticide resistance monitoring in malaria vector mosquitoes (Second edition)
Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale
False-negative RDT results and implications of new reports of P. falciparum HRP 2/3 gene deletions
Recommended selection criteria for procurement of malaria rapid diagnostic tests
World Malaria Day 2017
Other recent publications
Implications of insecticide resistance for malaria vector control
- Update on artemisinin and ACT resistance
- Malaria Policy Advisory Committee meeting report (September 2016)
WHO malaria terminology
World Malaria Report
Global Technical Strategy
Policy Advisory Committee
Call for applications for MPAC membership
Call for applications for membership on the Technical Expert Group on drug resistance and response
Call for applications for the Malaria Policy Advisory Committee
Call for nominations of experts to serve on a WHO Vector Control Advisory Group (VCAG) on new tools
Bi-annual letter to partners
Partners in the Greater Mekong Subregion mobilize around malaria elimination goal
Five-year WHO investigation shows that LLINs remain a highly effective tool in the malaria fight
The WHO Global Malaria Programme at the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene
More on malaria
This end-of-year video spotlights key developments in the global response to malaria in 2016.